Food safety regulator FSSAI will intensify crackdown on firms selling food products without its approval, following up on the Maggi controversy. Last week, GSK consumer healthcare re-launched it's ...

GlaxoSmithKline (GSK) has begun the sale of some of its consumer health brands ... Boutique investment bank Greenhill is to market the products to separate bidders, three anonymous sources ...

GlaxoSmithKline has announced its second major deal this month, signing an agreement with Pfizer to combine its consumer health business ... largest over-the-counter products firm in the world ...

GSK (GSK) announced the Committee for Medicinal Products for Human Use, CHMP, of the European Medicines Agency, EMA, has recommended expanding the approval of Jemperli in combination with chemotherapy ...

Seamless reading experience. Save your favourite. We have various options to advertise with us including Events, Advertorials, Banners, Mailers, etc.

as well new oral care products that address a range of people’s needs, including prevention of early periodontal disease (gingivitis) and reduction in tooth sensitivity. GSK Consumer Healthcare ...

He feels this is the ideal point for traders to buy the Glaxosmithkline Consumer Healthcare stock at Rs 4.000. He expects it to reach Rs 4800 in next six months or so. Advisory Alert: It has come ...

Though GSK is definitely not the best large-cap drugmaker to have in one's portfolio, we believe there is potential for its ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

The consumer healthcare division, whose portfolio of products includes also Centrum ... Heineken and Procter & Gamble in USA and in Brazil. GSK said on Saturday that it had received three ...

GSK has drawn on a vast bank of images and conversations from key global markets to help it establish a series of evolving “Health & Wellness Codes”. As GSK prepares to separate its pharma and ...